INVESTMENT
Invest in Transformative Life Science Technologies with Fryan
Fryan is a London-based life science innovation and investment company. We focus on technologies that combine strong commercial potential with measurable benefits for patients and the environment.
Competitive Advantages
We concentrate on:
- Medical & Bio-medical Technologies
- Pharmaceutical & Biopharmaceutical Platforms
- Advanced Chemistry & Biochemistry Solutions
We look for:
- Clear and pressing clinical or industrial needs
- Strong IP and scientific defensibility
- Credible regulatory and commercial pathways
- Alignment with global sustainability and ESG priorities
Why Partner with Fryan LTD?
- Based in London, Connected Globally
A strategic hub for science, finance and regulatory expertise. - Deep Technical Diligence
Strong scientific and clinical evaluation to manage risk. - Structured Value Creation
Clear milestones from proof-of-concept to scale-up. - Impact & ESG Integration
Health and environmental impact embedded from the outset.
Portfolio Highlights
- Non-Invasive Osteoporosis & Osteopenia Detection
- Water-Based, High-Performance Anti-Corrosion Technology
- Smart Biodegradable Patch for Diabetic Foot Ulcer Healing
Each opportunity offers investors exposure to large, growing markets with clear unmet needs.
What We Offer Investors
- Curated Innovation Pipeline
Access to a pipeline of vetted projects – such as non-invasive bone health diagnostics, green anti-corrosion platforms, and novel wound-healing solutions. - Scientific and Technical Diligence
Our team combines scientific, clinical, regulatory, and commercial expertise to thoroughly evaluate risks and opportunities.
What We Offer Investors
- Value Creation Strategy
From proof-of-concept and IP protection to pilot studies, clinical validation and industry partnerships, we build value at each stage. - Impact and ESG Integration
Our portfolio is designed to deliver positive social and environmental impact alongside financial return, supporting ESG-oriented investment strategies.
Collaboration Models
- Direct investment into specific platforms
- Joint ventures with industrial or strategic partners
- Co-development agreements
- Early-stage venture and growth capital for scaling validated technologies